Evidence map›Paper›PMID 27375820›Full record

ArticleBiomicrofluidics2016

Stability and efficacy of synthetic cationic antimicrobial peptides nebulized using high frequency acoustic waves.

Ying Wang, Amgad R Rezk, Jasmeet Singh Khara, Leslie Y Yeo, Pui Lai Rachel Ee

Abstract read
In one paragraph

Article in Biomicrofluidics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. [Advances in inhalable nano-formulations].Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences · 2025
    Review
  2. Review
  3. Low-dose intrapulmonary drug delivery device for studies on next-generation therapeutics in mice.Journal of controlled release : official journal of the Controlled Release Society · 2023
    Article
  4. Article
  5. Future Trends in Nebulized Therapies for Pulmonary Disease.Journal of personalized medicine · 2020
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ying WangDepartment of Pharmacy, National University of Singapore , 18 Science Drive 4, Singapore, Singapore 117543.
Amgad R RezkMicro/Nanophysics Research Laboratory, School of Civil, Environmental and Chemical Engineering, RMIT University , Melbourne, Victoria 3000, Australia.
Jasmeet Singh KharaDepartment of Pharmacy, National University of Singapore , 18 Science Drive 4, Singapore, Singapore 117543.
Leslie Y YeoMicro/Nanophysics Research Laboratory, School of Civil, Environmental and Chemical Engineering, RMIT University , Melbourne, Victoria 3000, Australia.ORCID 0000-0002-5949-9729
Pui Lai Rachel EeDepartment of Pharmacy, National University of Singapore , 18 Science Drive 4, Singapore, Singapore 117543.ORCID 0000-0002-7277-6233

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Surface acoustic wave (SAW), a nanometer amplitude electroelastic wave generated and propagated on low-loss piezoelectric substrates (such as LiNbO3), is an extremely efficient solid-fluid energy transfer mechanism. The present study explores the use of SAW nebulization as a solution for effective pulmonary peptide delivery. In vitro deposition characteristics of the nebulized peptides were determined using a Next Generation Cascade Impactor. 70% of the peptide-laden aerosols generated were within a size distribution favorable for deep lung distribution. The integrity of the nebulized peptides was found to be retained, as shown via mass spectrometry. The anti-mycobacterial activity of the nebulized peptides was found to be uncompromised compared with their non-nebulized counterparts, as demonstrated by the minimum inhibition concentration and the colony forming inhibition activity. The peptide concentration and volume recoveries for the SAW nebulizer were significantly higher than 90% and found to be insensitive to variation in the peptide sequences. These results demonstrate the potential of the SAW nebulization platform as an effective delivery system of therapeutic peptides through the respiratory tract to the deep lung.

Identifiers

PMID27375820
PMCPMC4902807

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.